Cargando…
Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment
Pasireotide improves hypercortisolemia and induces hyperglycemia via somatostatin receptor type‐5 stimulation. GLP‐1RA and SGLT2 inhibitor potentially help regulate hyperglycemia in patients with Cushing's disease, especially after pasireotide administration.
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752440/ https://www.ncbi.nlm.nih.gov/pubmed/33363790 http://dx.doi.org/10.1002/ccr3.3230 |
| _version_ | 1783625862825902080 |
|---|---|
| author | Shikata, Masato Ashida, Kenji Goto, Yuka Nagayama, Ayako Iwata, Shimpei Yano, Mamiko Hasuzawa, Nao Hara, Kento Mawatari, Kazutoshi Sakata, Kiyohiko Tsuruta, Munehisa Wada, Nobuhiko Nomura, Masatoshi |
| author_facet | Shikata, Masato Ashida, Kenji Goto, Yuka Nagayama, Ayako Iwata, Shimpei Yano, Mamiko Hasuzawa, Nao Hara, Kento Mawatari, Kazutoshi Sakata, Kiyohiko Tsuruta, Munehisa Wada, Nobuhiko Nomura, Masatoshi |
| author_sort | Shikata, Masato |
| collection | PubMed |
| description | Pasireotide improves hypercortisolemia and induces hyperglycemia via somatostatin receptor type‐5 stimulation. GLP‐1RA and SGLT2 inhibitor potentially help regulate hyperglycemia in patients with Cushing's disease, especially after pasireotide administration. |
| format | Online Article Text |
| id | pubmed-7752440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77524402020-12-23 Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment Shikata, Masato Ashida, Kenji Goto, Yuka Nagayama, Ayako Iwata, Shimpei Yano, Mamiko Hasuzawa, Nao Hara, Kento Mawatari, Kazutoshi Sakata, Kiyohiko Tsuruta, Munehisa Wada, Nobuhiko Nomura, Masatoshi Clin Case Rep Case Reports Pasireotide improves hypercortisolemia and induces hyperglycemia via somatostatin receptor type‐5 stimulation. GLP‐1RA and SGLT2 inhibitor potentially help regulate hyperglycemia in patients with Cushing's disease, especially after pasireotide administration. John Wiley and Sons Inc. 2020-08-13 /pmc/articles/PMC7752440/ /pubmed/33363790 http://dx.doi.org/10.1002/ccr3.3230 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Case Reports Shikata, Masato Ashida, Kenji Goto, Yuka Nagayama, Ayako Iwata, Shimpei Yano, Mamiko Hasuzawa, Nao Hara, Kento Mawatari, Kazutoshi Sakata, Kiyohiko Tsuruta, Munehisa Wada, Nobuhiko Nomura, Masatoshi Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| title | Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| title_full | Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| title_fullStr | Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| title_full_unstemmed | Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| title_short | Pasireotide‐induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| title_sort | pasireotide‐induced hyperglycemia in a patient with cushing's disease: potential use of sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist for treatment |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752440/ https://www.ncbi.nlm.nih.gov/pubmed/33363790 http://dx.doi.org/10.1002/ccr3.3230 |
| work_keys_str_mv | AT shikatamasato pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT ashidakenji pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT gotoyuka pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT nagayamaayako pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT iwatashimpei pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT yanomamiko pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT hasuzawanao pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT harakento pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT mawatarikazutoshi pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT sakatakiyohiko pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT tsurutamunehisa pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT wadanobuhiko pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment AT nomuramasatoshi pasireotideinducedhyperglycemiainapatientwithcushingsdiseasepotentialuseofsodiumglucosecotransporter2inhibitorandglucagonlikepeptide1receptoragonistfortreatment |